Video Shorts

Treatment and Clinical Trial Considerations in Myeloma Subgroups

OncLive News Roundup for the Week of 5/3

Highlighting the Importance of Raising Bladder Cancer Awareness

Evolving Management of p53-Mutated Mantle Cell Lymphoma

MANEUVER Trial Supports Integration of Targeted Therapy Into Upfront TGCT Management

Discussing the Implications of the SERENA-6 Trial Design

Addressing Challenges With Anemia Management in Myelofibrosis

Breaking Down the Current State of CAR T-Cell Therapies in PCNSL

MountainTAP-30 Trial Seeks to Leverage PRMT5 Inhibitor for MTAP-Deleted Pancreatic Cancer

Frontline Treatment and Transplant Considerations in Multiple Myeloma

The Pathologist's Role in Breast Cancer Biomarker Testing

Early RAS Inhibitor Data Signal Rare Momentum in Metastatic Pancreatic Cancer

Spotlighting the Nuances of the SERENA-6 Trial Design Following the FDA's ODAC Vote

Highlighting the Importance of Mentorship for Early-Career Cancer Researchers

Navigating JAK Inhibitors and Transplant in Myelofibrosis

OncLive News Roundup for the Week of 4/26

Highlighting Reconstructive Surgery Options in Breast Cancer

Breast Cancer Experts Discuss Emerging Data and Desicions

Examining the Potential Clinical Impact of the STRIKE Trial in RCC

GLP-1 Agonists Could Help Address Rising Rates of Early-Onset CRC

A New Era for RAS Inhibition in PDAC: From an “Undruggable” Target to a Potential Paradigm-Shifter

Breaking Down the Use of FES-PET/CT in Breast Cancer

The Push for Individualized Risk-Stratification Strategies in Myeloma

Is Surgery Still the Cornerstone of Curative Treatment in Esophageal Cancer?

Spotlighting Evolutions in HER2+ Breast Cancer Management

Examining the Treatment Landscape of Muscle-Invasive Bladder Cancer

OncLive News Roundup for the Week of 4/19

Discussing the Rationale for Evaluating a ROR2-Targeting ADC in OPSCC

Highlighting the Importance of Testicular Cancer Awareness

Could GLP-1 Receptor Agonists Help Reduce CRC Risk Beyond Weight Loss?